Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/2/15 → 12/2/18 |
Funding
- Parexel (Prot #INCB 52793-101 // Prot #INCB 52793-101)
- Incyte Corporation (Prot #INCB 52793-101 // Prot #INCB 52793-101)
Prot #INCB 52793-101: A Phase 1a/1b, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies
- Karmali, Reem (PD/PI)
- Kaplan, Jason B (Other)
Project: Research project